JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264871

Human STK40 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

STK40 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 8 bp deletion in exon 3. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human STK40 knockout HeLa cell line (AB264871)
  • Sanger seq

Unknown

Sanger Sequencing - Human STK40 knockout HeLa cell line (AB264871)

Homozygous : 8 bp deletion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 8 bp deletion in exon 3

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab264871-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255448 Human wild-type HeLa cell line", "number":"AB264871-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab264871 Human STK40 knockout HeLa cell line", "number":"AB264871-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab264871-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264871 Human STK40 knockout HeLa cell line", "number":"AB264871-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255448 Human wild-type HeLa cell line", "number":"AB264871-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264871-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264871 Human STK40 knockout HeLa cell line", "number":"AB264871-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264871-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264871 Human STK40 knockout HeLa cell line", "number":"AB264871-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
STK40
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

STK40 also known as Serine/Threonine Kinase 40 or protein-cancelled testis is an important kinase involved in several cellular processes. This protein has a mass of approximately 52 kDa. STK40 is mainly expressed in embryonic tissues and adult testis but also observed in many other tissues highlighting its various roles during development and in adult organisms. STK40 functions by phosphorylating target proteins which affects their function and regulates their activities within the cell.
Biological function summary

STK40 influences cell differentiation and development. It forms part of signaling complexes interacting with various other proteins to impart its effect. STK40 influences pluripotency in stem cells by modulating transcription factors and signaling pathways critical for maintaining a stable differentiation state. Moreover STK40 is shown to play a role in adipogenesis by affecting pathways that control fat cell formation and distribution.

Pathways

STK40 functions actively within several signaling cascades notably the MAPK and Wnt pathways. In the MAPK pathway it coordinates with proteins like MAP3K7 to control transcriptional activation linked to cellular stress responses and differentiation processes. In the Wnt signaling pathway STK40 influences the stabilization of beta-catenin a central protein in regulating gene expression related to cell proliferation and fate decisions.

STK40 has connections to cancer and metabolic syndromes. Dysregulation of STK40 expression or function can lead to improper cell differentiation and proliferation contributing to tumorigenesis particularly in testicular cancer. In metabolic disorders such as obesity STK40's role in adipogenesis can affect fat deposition and might interlink with other proteins like PPARγ which further influences lipid metabolism and insulin sensitivity. Understanding STK40's role in these conditions highlights its potential as a therapeutic target.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com